Crush The Market

undefined Logo

Novavax, Inc.

16.51 USD

-4.68%

Add To Watchlist

Page 1 of 26

2021-1996

Currency in USD2021
PeriodFY
Revenue1.15 Billion
Cost Of Revenue0.00
Gross Profit0.00
Gross Profit Ratio0.00
Research And Development Expenses2.53 Billion
General And Administrative Expenses298.36 Million
Selling And Marketing Expenses0.00
Selling General And Administrative Expenses298.36 Million
Other Expenses0.00
Operating Expenses2.83 Billion
Cost And Expenses2.83 Billion
Interest Income0.00
Interest Expense21.13 Million
Depreciation And Amortization12.66 Million
Ebitda-1.68 Billion
Ebitdaratio-1.47
Operating Income-1.69 Billion
Operating Income Ratio-1.47
Total Other Income Expenses Net-27.96 Million
Income Before Tax-1.71 Billion
Income Before Tax Ratio-1.50
Income Tax Expense29.21 Million
Net Income-1.74 Billion
Net Income Ratio-1.52
Eps-23.44
Epsdiluted-23.44
Weighted Average Shs Out74.40 Million
Weighted Average Shs Out Dil74.40 Million
Linkhttps://www.sec.gov/Archives/edgar/data/1000694/000100069422000004/0001000694-22-000004-index.htm
Final Linkhttps://www.sec.gov/Archives/edgar/data/1000694/000100069422000004/nvax-20211231.htm

Crush The Market

We Use Cookies